UBA6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.879200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.985000E-01
Normal-vs-Stage2
8.520400E-01
Normal-vs-Stage3
6.210800E-01
Normal-vs-Stage4
7.441000E-01
Stage1-vs-Stage2
4.554400E-01
Stage1-vs-Stage3
7.163800E-01
Stage1-vs-Stage4
4.422600E-01
Stage2-vs-Stage3
3.380200E-01
Stage2-vs-Stage4
6.287800E-01
Stage3-vs-Stage4
4.537400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.009400E-01
Normal-vs-AfricanAmerican
9.794800E-01
Normal-vs-Asian
8.773200E-01
Caucasian-vs-AfricanAmerican
8.246200E-01
Caucasian-vs-Asian
9.112600E-01
AfricanAmerican-vs-Asian
8.195400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.062400E-01
Normal-vs-Female
8.561800E-01
Male-vs-Female
8.457200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.796400E-01
Normal-vs-Age(41-60Yrs)
5.445600E-01
Normal-vs-Age(61-80Yrs)
9.702800E-01
Normal-vs-Age(81-100Yrs)
7.436800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.266200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.304000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.271000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.202400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.656300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.091400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.203200E-01
Normal-vs-Daily Drinker
7.915400E-01
Normal-vs-Weekly Drinker
8.538200E-01
Normal-vs-Occasional Drinker
4.156600E-01
Normal-vs-Social Drinker
7.761800E-01
Non Drinker-vs-Daily Drinker
7.755600E-01
Non Drinker-vs-Weekly Drinker
9.325000E-01
Non Drinker-vs-Occasional Drinker
8.514000E-02
Non Drinker-vs-Social Drinker
5.052400E-01
Daily Drinker-vs-Weekly Drinker
8.522800E-01
Daily Drinker-vs-Occasional Drinker
3.620000E-02
Daily Drinker-vs-Social Drinker
3.084200E-01
Weekly Drinker-vs-Occasional Drinker
7.013700E-02
Weekly Drinker-vs-Social Drinker
4.089800E-01
Occasional Drinker-vs-Social Drinker
2.816600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.200990E-01
Normal-vs-Grade 2
3.538100E-02
Normal-vs-Grade 3
1.815820E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.011600E-02
Grade 1-vs-Grade 3
1.119710E-02
Grade 1-vs-Grade 4
1.200990E-01
Grade 2-vs-Grade 3
5.308000E-01
Grade 2-vs-Grade 4
3.538100E-02
Grade 3-vs-Grade 4
1.815820E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.208800E-01
Normal-vs-NonDiabetic
8.115600E-01
Diabetic-vs-NonDiabetic
5.213700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.990000E-01
Normal-vs-NoPancreatitis
9.313800E-01
Pancreatitis-vs-NoPancreatitis
8.287000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.408400E-01
Normal-vs-N1
9.007600E-01
N0-vs-N1
6.599800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.277400E-01
Normal-vs-TP53-NonMutant
7.550000E-01
TP53-Mutant-vs-TP53-NonMutant
1.584160E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
